Parul Gupta,1 Manjri Singh,2 Rajiv Kumar,3 Jodi Belz,3 Rishi Shanker,4 Premendra D Dwivedi,1 Srinivas Sridhar,3 Surinder P Singh2 1CSIR-Indian Institute of Toxicological Research, Lucknow, 2CSIR-National Physical Laboratory, New Delhi, India; 3Nanomedicine Science and Technology Center, Northeastern University, Boston, MA, USA; 4Institute of Life Sciences, Ahmedabad University, Ahmedabad, India Abstract: Advances in nanotechnology have led to the design of multifunctional nanoparticles capable of cellular imaging, targeted drug delivery, and diagnostics for early cancer detection. We synthesized poly(lactic-co-glycolic acid) nanoparticles encapsulating a model radiosensitizing drug docetaxel accomplishing localized in situ delivery of the...
Abstract Cancer is the leading cause of death worldwide. Nanomaterials and nanotechnologies could pr...
Pedram Rafiei, Azita Haddadi Division of Pharmacy, College of Pharmacy and Nutrition, University of...
Despite recent advancements in cisplatin (cis-diamminedichloroplatinum II) and other platinum-based ...
In the present study, we developed novel docetaxel (DTX)-loaded polylactic acid-co-glycolic acid (PL...
Intestinal cancers are the third most lethal cancers globally, beginning as polyps in the intestine ...
Breast cancer is the leading cause of cancer-related death in women. Although many therapeutic appro...
Mona Noori Koopaei1, Rassoul Dinarvand1,2, Mohsen Amini3, Hojatollah Rabbani4, Shaghayegh Emami4, Se...
Non-specificity and drug resistance are two major limitations of all chemotherapeutic agents. Ligand...
This study investigates the potentiality of nanosphere colloidal suspensions as sustained release sy...
In spite of extensive research over the decades, breast cancer treatment is still a major challenge ...
Paclitaxel (PTX), cytotoxic agent extracted from Taxus brevifolia has significant antineoplastic act...
In this study a 3-factor, 3-level Box-Behnken design was used to prepare optimized docetaxel (DTX) l...
Aim: To formulate and assess the anticancer effect of the poly(lactic-co-glycolic acid) (PLGA) copol...
Purpose This study was carried out to formulate poly(lactide-co-glycolide) (PLGA) nanoparticles usin...
Abstract: Paclitaxel (PTX) is a cytotoxic agent derived from Taxus brevifolia used for lung cancer. ...
Abstract Cancer is the leading cause of death worldwide. Nanomaterials and nanotechnologies could pr...
Pedram Rafiei, Azita Haddadi Division of Pharmacy, College of Pharmacy and Nutrition, University of...
Despite recent advancements in cisplatin (cis-diamminedichloroplatinum II) and other platinum-based ...
In the present study, we developed novel docetaxel (DTX)-loaded polylactic acid-co-glycolic acid (PL...
Intestinal cancers are the third most lethal cancers globally, beginning as polyps in the intestine ...
Breast cancer is the leading cause of cancer-related death in women. Although many therapeutic appro...
Mona Noori Koopaei1, Rassoul Dinarvand1,2, Mohsen Amini3, Hojatollah Rabbani4, Shaghayegh Emami4, Se...
Non-specificity and drug resistance are two major limitations of all chemotherapeutic agents. Ligand...
This study investigates the potentiality of nanosphere colloidal suspensions as sustained release sy...
In spite of extensive research over the decades, breast cancer treatment is still a major challenge ...
Paclitaxel (PTX), cytotoxic agent extracted from Taxus brevifolia has significant antineoplastic act...
In this study a 3-factor, 3-level Box-Behnken design was used to prepare optimized docetaxel (DTX) l...
Aim: To formulate and assess the anticancer effect of the poly(lactic-co-glycolic acid) (PLGA) copol...
Purpose This study was carried out to formulate poly(lactide-co-glycolide) (PLGA) nanoparticles usin...
Abstract: Paclitaxel (PTX) is a cytotoxic agent derived from Taxus brevifolia used for lung cancer. ...
Abstract Cancer is the leading cause of death worldwide. Nanomaterials and nanotechnologies could pr...
Pedram Rafiei, Azita Haddadi Division of Pharmacy, College of Pharmacy and Nutrition, University of...
Despite recent advancements in cisplatin (cis-diamminedichloroplatinum II) and other platinum-based ...